Atlas Trials

To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults

Clinical trial NCT06578676 · RECRUITING

Trial details

NCT number
NCT06578676
Sponsor
Hyundai Pharm
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 DiabetesDyslipidemias
Start date
2024-06-20
Primary completion
2024-09-02
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.